Rutika Mehta
- Cancer Research top 5%
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 11
- HER2/EGFR in Cancer Research 6
- Pathology and Forensic Medicine top 10%
-
- Gastric Cancer Management and Outcomes 25
- Lung Cancer Treatments and Mutations 6
-
- Esophageal Cancer Research and Treatment 17
- Esophageal and GI Pathology 8
- Colorectal and Anal Carcinomas 5
-
- Gastrointestinal Tumor Research and Treatment 8
- Co-authors
- Sunil BadveRohit JainHarikrishna NakshatriJorge S. Reis‐FilhoMangesh A. ThoratErika ResetkovaMuhammad T. IdreesRichard D. Kim
- Partner nations
- United StatesCanadaSouth Korea
In The Last Decade
Rutika Mehta
67 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 331
- Oncology 556
- Pathology and Forensic Medicine 184
- Pulmonary and Respiratory Medicine 295
- Molecular Biology 468
Countries citing papers authored by Rutika Mehta
This map shows the geographic impact of Rutika Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rutika Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rutika Mehta more than expected).
Fields of papers citing papers by Rutika Mehta
This network shows the impact of papers produced by Rutika Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rutika Mehta. The network helps show where Rutika Mehta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rutika Mehta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2022 | 53 | |
| 6 | 2021 | 28 | |
| 7 | 2020 | 23 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 13 | |
| 12 | 2016 | 14 | |
| 13 | Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer | 2014 | 2 |
| 14 | 2014 | 10 | |
| 15 | 2011 | 104 | |
| 16 | 2011 | 57 | |
| 17 | 2010 | 15 | |
| 18 | 2010 | 13 | |
| 19 | 2010 | 33 | |
| 20 | 2010 | 41 |
About Rutika Mehta
Rutika Mehta is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 73 papers that have together received 1.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (25 papers), Esophageal Cancer Research and Treatment (17 papers), Colorectal Cancer Treatments and Studies (11 papers), Gastrointestinal Tumor Research and Treatment (8 papers), Esophageal and GI Pathology (8 papers), HER2/EGFR in Cancer Research (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Colorectal and Anal Carcinomas (5 papers). The work is most often cited by research in Cancer Research (331 citations), Oncology (556 citations) and Pathology and Forensic Medicine (184 citations). Rutika Mehta has collaborated with scholars based in United States, Canada and South Korea. Frequent co-authors include Sunil Badve, Rohit Jain, Harikrishna Nakshatri, Jorge S. Reis‐Filho, Mangesh A. Thorat, Erika Resetkova, Muhammad T. Idrees, Richard D. Kim, Yesim Gökmen‐Polar and Samuel Leung.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.